AMEL ELSHAIER: Open Payments
NPI 1780166819 · CRIVITZ, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 26 payments from 6 companies in 2025. Trend: 2023 $624 · 2024 $542 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $86 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Merck Sharp & Dohme LLC | 5 | $78 |
| Lilly USA, LLC | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: JARDIANCE, REPATHA, OTEZLA, VERQUVO, LEQVIO, MOUNJARO, ENTRESTO, CAPVAXIVE.
Industry payments across WI — which companies pay providers there.
